Sanofi SA (SNY)
49.32
+2.70
(+5.80%)
USD |
NASDAQ |
Apr 25, 16:00
49.32
0.00 (0.00%)
After-Hours: 20:00
Sanofi EPS Diluted (Quarterly): -0.2369 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.2369 |
| September 30, 2023 | 1.094 |
| June 30, 2023 | 0.627 |
| March 31, 2023 | 0.8592 |
| December 31, 2022 | 0.5931 |
| September 30, 2022 | 0.8361 |
| June 30, 2022 | 0.5006 |
| March 31, 2022 | 0.9033 |
| December 31, 2021 | 0.5147 |
| September 30, 2021 | 1.085 |
| June 30, 2021 | 0.5764 |
| March 31, 2021 | 0.7531 |
| June 30, 2020 | 3.331 |
| March 31, 2020 | 0.7449 |
| December 31, 2019 | -0.0055 |
| September 30, 2019 | 0.7839 |
| June 30, 2019 | -0.0393 |
| March 31, 2019 | 0.5169 |
| December 31, 2018 | 0.1141 |
| September 30, 2018 | 1.058 |
| June 30, 2018 | 0.3642 |
| March 31, 2018 | 0.4975 |
| December 31, 2017 | 0.0589 |
| September 30, 2017 | 0.7348 |
| June 30, 2017 | 0.4511 |
| Date | Value |
|---|---|
| March 31, 2017 | 2.408 |
| December 31, 2016 | 0.3344 |
| September 30, 2016 | 0.7255 |
| June 30, 2016 | 0.5084 |
| March 31, 2016 | 0.4633 |
| December 31, 2015 | 0.1422 |
| September 30, 2015 | 0.6946 |
| June 30, 2015 | 0.5525 |
| March 31, 2015 | 0.44 |
| December 31, 2014 | 0.6369 |
| September 30, 2014 | 0.603 |
| June 30, 2014 | 0.4046 |
| March 31, 2014 | 0.5617 |
| December 31, 2013 | 0.5445 |
| September 30, 2013 | 0.6097 |
| June 30, 2013 | 0.222 |
| March 31, 2013 | 0.4951 |
| December 31, 2012 | 0.2011 |
| September 30, 2012 | 0.7314 |
| June 30, 2012 | 0.565 |
| March 31, 2012 | 0.8981 |
| December 31, 2011 | 0.6938 |
| September 30, 2011 | 1.074 |
| June 30, 2011 | 0.5367 |
| March 31, 2011 | 0.6361 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.2369
Minimum
Dec 2023
3.331
Maximum
Jun 2020
0.76
Average
0.7449
Median
Mar 2020
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.31 |
| GSK PLC | 0.2111 |
| Novo Nordisk A/S | 0.7086 |
| Regeneron Pharmaceuticals Inc | 10.19 |
| Inhibrx Inc | -1.82 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -597.68M |
| Revenue (Quarterly) | 13.14B |
| Total Expenses (Quarterly) | 11.04B |
| Enterprise Value | 124.93B |
| Gross Profit Margin (Quarterly) | 66.82% |
| Profit Margin (Quarterly) | -4.55% |
| Earnings Yield | 4.75% |
| Operating Earnings Yield | 9.12% |
| Normalized Earnings Yield | 6.441 |